The risk of secondary primary malignancies after therapy for multiple myeloma
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.974043
Reference45 articles.
1. Multiple Myeloma and Acute Myelomonocytic Leukemia
2. The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia
3. Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
4. Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
5. Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?;Cancers;2023-07-03
2. Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship;Nature Reviews Clinical Oncology;2023-05-25
3. Secondary primary malignancies in patients with multiple myeloma: A single institution experience;Hematological Oncology;2021-09-12
4. Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients;Cureus;2021-07-13
5. Patterns of previous and secondary malignancies in patients with multiple myeloma;European Journal of Haematology;2021-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3